Compare SNES & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNES | HKPD |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | 27 |
| Industry | Agricultural Chemicals | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 6.9M |
| IPO Year | 2016 | N/A |
| Metric | SNES | HKPD |
|---|---|---|
| Price | $1.63 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.8K | ★ 396.3K |
| Earning Date | 05-07-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,000.00 | N/A |
| Revenue This Year | $29.00 | N/A |
| Revenue Next Year | $95.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.56 | N/A |
| 52 Week Low | $1.41 | $0.32 |
| 52 Week High | $5.99 | $2.58 |
| Indicator | SNES | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 37.85 |
| Support Level | $1.55 | $0.34 |
| Resistance Level | $1.76 | $0.71 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 40.38 | 35.46 |
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.